Antigens expressed on carbohydrates are difficult to include in the design of an effective vaccination approach for tumors. Prevention of some pathogen infection is hampered by the lack of effective immunization due to toxicity and/or poor immunogenicity of polysaccharide derived vaccines in the target population of immunocompromised individuals and young children. Peptide mimotopes of carbohydrate antigens provide an alternative approach to vaccination. The concept of mimicry holds enormous promise; a molecule that mimics a given antigen by eliciting a similar immune response is potentially useful as a vaccine, and is defined as a mimotope. Specific topics that are impacted by this proposal as related to cancer immunotherapy include: 1) The ability and mechanism(s) by which peptides can mimic carbohydrate antigen; (2) The ability and mechanism(s) by which mimetic peptides can induce anti-carbohydrate immune-responses; (3) The use of peptide based mimetics as tumor vaccines employing a variety of delivery modalities; and (4) The mechanism(s) of tumor immunity induced by peptide mimetics in murine models. In the first aim, the molecular interactions underlying mimicry are assessed using molecular modeling and analysis of kinetic and thermodynamic parameters associated with complex formation. In the second aim, we evaluate basic mechanisms associated with immunological mimicry. We examine aspects of the humoral and cellular responses induced by peptide mimotopes as compared with nominal antigen formulations. Contrasting the immunological presentation of peptide mimotopes with that of carbohydrate antigens and their conjugates provides a basis for understanding immunological mimicry necessary to enhance carbohydrate cross-reactive immune responses. In the third aim we define immune mechanisms that provide anti-tumor protection by using several in vivo models, focusing on methodologies to target peptide immunogens to specific antigen-presenting cells and antigen-processing pathways.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA089480-01A2
Application #
6598272
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-05-13
Project End
2006-04-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Murali, Ramachandran; Greene, Mark I (2012) Structure based antibody-like peptidomimetics. Pharmaceuticals (Basel) 5:209-35
Ponde, Datta E; Su, ZiFen; Berezov, Alan et al. (2011) Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent. Bioorg Med Chem Lett 21:2550-3
Monzavi-Karbassi, Behjatolah; Hine, R Jean; Stanley, Joseph S et al. (2010) Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. Int J Oncol 37:615-22
Zhang, Tianqian; Herlyn, Dorothee (2009) Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer. Cancer Immunol Immunother 58:475-92
Cai, Z; Zhang, G; Zhou, Z et al. (2008) Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes. Oncogene 27:3870-4
Wondimu, Assefa; Zhang, Tianqian; Kieber-Emmons, Thomas et al. (2008) Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice. Cancer Immunol Immunother 57:1079-89
Monzavi-Karbassi, Behjatolah; Stanley, J Steven; Hennings, Leah et al. (2007) Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer 120:1179-91
Ko, Eric; Luo, Wei; Peng, Liaomin et al. (2007) Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity. Cancer Res 67:7875-84
Zhang, Hongtao; Berezov, Alan; Wang, Qiang et al. (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117:2051-8
Whitehead, Tracy L; Holley, Andy W; Korourian, Soheila et al. (2007) (1)H nuclear magnetic resonance metabolomic analysis of mammary tumors from lean and obese Zucker rats exposed to 7,12-dimethylbenz[a]anthracene. Int J Mol Med 20:573-80

Showing the most recent 10 out of 40 publications